Continuous Manufacturing Market (Small Molecules and Biologics), 2020

To order this 310+ page report, which features 110+ figures and 200+ tables, please visit this – https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

Purpose of Manufacturing

Scale of Operation

Type of Continuous Manufacturing related Service

API Manufacturing

End Product manufacturing

Type of Drug Molecule

Type of dosage form

Key Geographical Regions

North America

Europe

Asia Pacific

Transcripts of interviews held with the following senior level representatives of stakeholder companies
Andrea Adamo, Founder and Chief Executive Officer, Zaiput Flow technologies
Bayan Takizawa, Co-Founder and Chief Business Officer, CONTINUUS Pharmaceuticals
Nick Thomson, Senior Director Chemical Research and Development, Pfizer
Himanshu Gadgil, Director and Chief Scientific Officer, Enzene Biosciences
Eric Fang, Chief Scientific Officer, Snapdragon Chemistry)
Ian Houson, Technical Project Manager, Continuous Manufacturing and Crystallization, University of Strathclyde

Key Questions Answered

Who are the key players engaged in continuous manufacturing of small molecules and biologics?
What is the installed, global capacity for continuous manufacturing?
What are the key growth drivers within this domain?
What are the various paths to evolution within this industry?
Who are the other key stakeholders (modular facility providers and technology / equipment developers) in this domain?
How is the current and future market opportunity likely to be distributed across key market segments?

You may also be interested in the following titles: